Redhill Biopharma (RDHL) Stock: Buy, Sell, or Hold?
RDHL - Redhill Biopharma Ltd.
$0.50
0.02 (3.94%)
▲
5d:
-6.46%
30d:
-12.19%
90d:
-27.68%
HOLD
LOW Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Apr 09, 2026
0d
Get Alerted When RDHL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RDHL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RDHL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RDHL is currently trading at $0.50, which is considered slightly low relative to its 30-day fair value range of $0.48 to $0.58.
Technical Outlook: Technically, RDHL is in a strong downtrend. Immediate support is located at $0.44, while resistance sits at $0.69. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: RDHL scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19000.00 (+3957408.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RDHL is in a strong downtrend. Immediate support is located at $0.44, while resistance sits at $0.69. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: RDHL scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19000.00 (+3957408.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.48 -
$0.58
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading 3957408.9% below Wall St target ($19000.00)
- BULLISH: Bottoming setup score 68/100 — corrected, stabilizing, and turning up
- CAUTION: Recommendation downgraded due to -6.5% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.48 -
$0.58
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.44
Resistance Level
$0.69
Current Trend
Strong Downtrend
Technical data as of
Oct 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1428.57
Wall Street Target
$19000.00
(+3957408.9%)
Revenue Growth (YoY)
58.6%
Share & Embed Analysis
Last updated: October 19, 2026 1:33 PM ET
Data refreshes hourly during market hours. Next update: 2:33 PM
Data refreshes hourly during market hours. Next update: 2:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDHL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$207 | 49 HOLD |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 58 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 50 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 63 BUY |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$65 | 56 HOLD |
